Evidence map›Paper›PMID 19023450›Full record

ArticleMolecular vision2008

Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy.

J Liu, M Saghizadeh, S S Tuli, A A Kramerov, A S Lewin, D C Bloom, W W Hauswirth, M G Castro, G S Schultz, A V Ljubimov

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. [Gene therapy in ophthalmology].Die Ophthalmologie · 2023
    Review
  2. Review
  3. Article
  4. Heterogeneity of human corneal endothelium implicates lncRNAMolecular therapy. Nucleic acids · 2022
    Article
  5. Gene Therapy in the Anterior Eye Segment.Current gene therapy · 2022
    Review
  6. Review
  7. Article
  8. Novel insights into gene therapy in the cornea.Experimental eye research · 2021
    Review
  9. Review
  10. Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges.Applied biosafety : journal of the American Biological Safety Association · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Progress in corneal wound healing.Progress in retinal and eye research · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

J LiuDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA.
M Saghizadeh
S S Tuli
A A Kramerov
A S Lewin
D C Bloom
W W Hauswirth
M G Castro
G S Schultz
A V Ljubimov
University of Florida · US

Funding

ZONA-FREE HAMSTER OVA ASSAY AS AN INDICATOR OF MALE FERTILITYM01RR000425 · NCRR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI ANDERSON, GAIL V · 1985 to 2011
$74.2M
Mechanisms of Epithelial Alterations in Diabetic CorneaR01EY013431 · NEI · CEDARS-SINAI MEDICAL CENTER · PI Alexander V Ljubimov · 2001 to 2026
$11.3M
REGULATION OF STROMAL WOUND HEALING BY GROWTH FACTORSR01EY005587 · NEI · UNIVERSITY OF LOUISVILLE · PI SCHULTZ, GREGORY SCOTT · 1985 to 2014
$4.1M
Gutless Adenovirus Mediated Gene Therapy for GliomaU01NS052465 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CASTRO, MARIA G · 2007 to 2011
$3.1M
Gene therapy for chronic neurodegenerative disordersR01NS044556 · NINDS · CEDARS-SINAI MEDICAL CENTER · PI CASTRO, MARIA G · 2002 to 2006
$2.0M
NCRR NIH HHS M01 RR000425NCRR NIH HHS M01 RR00425NEI NIH HHS EY05587NEI NIH HHS EY13431NEI NIH HHS R01 EY005587NEI NIH HHS R01 EY013431NINDS NIH HHS NS052465NINDS NIH HHS NS44556NINDS NIH HHS R01 NS044556NINDS NIH HHS U01 NS052465
6 · The paper itself

Abstract

purposeDiseased corneas are potential targets for viral-based gene therapy to normalize (stimulate or inhibit) the expression of specific proteins. The choice of viral vectors is important to achieve optimal effect. The purpose of this study was to compare the tropism to different corneal cells of recombinant adenovirus (rAV) and recombinant adeno-associated virus (rAAV) constructs using live rabbit and organ-cultured human corneas.

methodsrAV constructs harbored the green fluorescent protein (GFP) gene under the control of major immediate early cytomegalovirus (CMV) promoter. rAAV constructs from virus serotypes 1, 2 5, 7, and 8 had GFP under the chicken beta-actin promoter and CMV enhancer. For organ culture, 16 healthy and diabetic postmortem human corneas were used. Five or fifteen microl rAV at 10(7) plaque forming units per 1 microl were added for 2 days to culture medium of uninjured corneas that were further cultured for 5-32 days. rAAV were added at 1.2-7.8x10(10) vector genomes per cornea for 3 days to each cornea; the culture then continued for another 14-23 days. Corneal cryostat sections were examined by immunohistochemistry. Live rabbit corneas were used following excimer laser ablation of the corneal epithelium with preservation of the basal cell layer. Equal numbers of rAAV particles (2x10(11) vector genomes) were applied to the cornea for 10 min. After seven days to allow for corneal healing and gene expression the animals were euthanized, the corneas were excised, and sections analyzed by immunohistochemistry.

resultsBy direct fluorescence microscopy of live organ-cultured human corneas GFP signal after rAV transduction was strong in the epithelium with dose-dependent intensity. On corneal sections, GFP was seen in all epithelial layers and some endothelial cells but most keratocytes were negative. In rAAV-transduced organ-cultured human corneas GFP signal could only be detected with anti-GFP antibody immunohistochemistry. GFP was observed in the epithelium, keratocytes, and endothelium, with more pronounced basal epithelial cell staining with rAAV1 than with other serotypes. No difference in the GFP expression patterns or levels between normal and diabetic corneas was noted. The rabbit corneas showed very similar patterns of GFP distribution to human corneas. With all rAAV serotype vectors, GFP staining in the epithelium was significantly (p=0.007) higher than the background staining in non-transduced corneas, with a trend for rAAV1 and rAAV8 to produce higher staining intensities than for rAAV2, rAAV5 (p=0.03; rAAV5 versus rAAV1), and rAAV7. rAAV serotype vectors also transduced stromal and endothelial cells in rabbit corneas to a different extent.

conclusionsrAAV appears to reach many more corneal cells than rAV, especially keratocytes, although GFP expression levels were lower compared to rAV. rAV may be more useful than rAAV for gene therapy applications requiring high protein expression levels, but rAAV may be superior for keratocyte targeting.

Indexed as

Genetic TherapyAdenoviridaeAnimalsChickensCorneaDependovirusDiabetes MellitusEpithelium, CornealGenetic VectorsGreen Fluorescent ProteinsHumansOrgan Culture TechniquesOrgan SpecificityRabbitsTransduction, GeneticGreen Fluorescent Proteins

Identifiers

PMID19023450
PMCPMC2584774
OpenAlexW1579432655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.